CHRISTINE T WANJERI HASEN
Allopathic & Osteopathic Physicians|Family Medicine BENSALEM, PA NPI 1013202803
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine PA E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$1,773.55
- Category: General Payments
- Program years: PY2018–2024
- Record count: 58
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $314.77 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $314.77 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $124.99 | 1 |
| ABBVIE INC. | $69.30 | 1 |
| Abbott Laboratories | $41.77 | 2 |
| Lilly USA, LLC | $34.50 | 2 |
| Acerta Pharma LLC | $23.38 | 1 |
| Novo Nordisk AS | $20.83 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096753955 | Novo Nordisk Inc | $20.83 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101790108 | E.R. Squibb & Sons, L.L.C. | $124.99 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104423851 | AstraZeneca Pharmaceuticals LP | $23.38 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106307785 | ABBVIE INC. | $69.30 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124793100 | Abbott Laboratories | $20.29 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124793102 | Abbott Laboratories | $21.48 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136108110 | Lilly USA, LLC | $13.88 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136120712 | Lilly USA, LLC | $20.62 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.